InDex Pharmaceuticals Holding AB(SE:FLERIE)
kr 13.10+0.20 (+1.55%)
SE:FLERIE
InDex Pharmaceuticals Holding AB financials statements
kr 13.10
At close:+0.20 (+1.55%)
Want to see SE:FLERIE full AI Analyst Report?
InDex Pharmaceuticals Holding AB (FLERIE) Income Statement
2 Followers
InDex Pharmaceuticals Holding AB Income Statement
Last quarter (Q3 2026), InDex Pharmaceuticals Holding AB's total revenue was kr900.00K, an increase of 106.00% from the same quarter last year. In Q3, InDex Pharmaceuticals Holding AB's net income was kr-280.60M. See InDex Pharmaceuticals Holding AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 8.80M | kr 100.00K | kr 97.50M | kr 0.00 | kr 0.00 | |
| kr -12.70M | kr -41.60M | kr 93.35M | kr -1.07M | kr -1.25M | |
| kr 769.40M | kr 275.10M | kr 200.71M | kr 150.05M | kr 114.38M | |
| Depreciation and Amortization | kr 600.00K | kr 800.00K | kr 1.22M | kr 1.07M | kr 1.25M |
| kr -743.60M | kr -225.70M | kr -93.82M | kr -99.15M | kr -101.66M | |
| kr -782.10M | kr -110.80M | kr -107.37M | kr -151.11M | kr -115.63M | |
| kr 24.20M | kr -117.10M | kr 12.10M | kr 50.78M | kr 12.59M | |
| kr -757.90M | kr -227.90M | kr -95.27M | kr -100.33M | kr -103.04M | |
| kr -756.90M | kr -228.00M | kr -95.27M | kr -100.33M | kr -103.04M | |
| Per Share Metrics | |||||
| Basic EPS | kr -9.71 | kr -3.24 | kr -17.88 | kr -18.84 | kr -21.32 |
| Diluted EPS | kr -9.71 | kr -3.24 | kr -17.88 | kr -18.84 | kr -21.32 |
| Weighted Average Shares Outstanding | 77.95M | 70.47M | 53.27M | 53.27M | 48.34M |
| Weighted Average Shares Outstanding (Diluted) | 77.95M | 70.47M | 53.27M | 53.27M | 48.34M |
Currency in SEK

